Citations (62)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (10)
Gianpaolo Perletti, Alberto Trinchieri, Konstantinos Stamatiou & Vittorio Magri. (2022) Safety considerations with new antibacterial approaches for chronic bacterial prostatitis. Expert Opinion on Drug Safety 21:2, pages 171-182.
Read now
Read now
Fahadullah Khan, Mohammad Ismail, Qasim Khan & Zahid Ali. (2018) Moxifloxacin-induced QT interval prolongation and torsades de pointes: a narrative review. Expert Opinion on Drug Safety 17:10, pages 1029-1039.
Read now
Read now
Elyse Cornett, Matthew B. Novitch, Alan D. Kaye, Chris A. Pann, Harish Siddaiah Bangalore, Gregory Allred, Matthew Bral, Preya K. Jhita & Adam M. Kaye. (2017) Macrolide and fluoroquinolone mediated cardiac arrhythmias: clinical considerations and comprehensive review. Postgraduate Medicine 129:7, pages 715-724.
Read now
Read now
Minhui Hu, Chunlan Zheng & Feng Gao. (2016) Use of bedaquiline and delamanid in diabetes patients: clinical and pharmacological considerations. Drug Design, Development and Therapy 10, pages 3983-3994.
Read now
Read now
Mao Hagihara, Jared L Crandon & David P Nicolau. (2012) The efficacy and safety of antibiotic combination therapy for infections caused by Gram-positive and Gram-negative organisms. Expert Opinion on Drug Safety 11:2, pages 221-233.
Read now
Read now
Fernando J Martinez, Jeffrey L Curtis & Richard Albert. (2008) Role of macrolide therapy in chronic obstructive pulmonary disease. International Journal of Chronic Obstructive Pulmonary Disease 3:3, pages 331-350.
Read now
Read now
Paul B. Iannini. (2007) The safety profile of moxifloxacin and other fluoroquinolones in special patient populations. Current Medical Research and Opinion 23:6, pages 1403-1413.
Read now
Read now
Kathy N Williams & William R Bishai. (2005) Clarithromycin extended-release in community-acquired respiratory tract infections. Expert Opinion on Pharmacotherapy 6:16, pages 2867-2876.
Read now
Read now
Rachel Norwood & Ronald Balkissoon. (2005) Current Perspectives on Management of Co-Morbid Depression in COPD. COPD: Journal of Chronic Obstructive Pulmonary Disease 2:1, pages 185-193.
Read now
Read now
Fadia T Shaya, James Y Shin, Winston I Wong & Woodrow Proveaux. (2004) Clinical and economic evaluation of gatifloxacin and levofloxacin. Expert Review of Pharmacoeconomics & Outcomes Research 4:4, pages 469-477.
Read now
Read now
Articles from other publishers (52)
N. V. Izmozherova, V. M. Bakhtin, A. A. Yakovleva, M. A. Bashindzhagyan, E. A. Makarov & K. A. Kabanova. (2023) Effect of fluoroquinolones on the cardiovascular system of laboratory rabbits. Ural Medical Journal 22:1, pages 72-77.
Crossref
Crossref
Nils Wetzstein, Janne J. Vehreschild & Maria J. G. T. Vehreschild. 2020. Die Intensivmedizin. Die Intensivmedizin
1
13
.
Noha E. Farag, Mohamed K. El-Kherbetawy, Hussein M. Ismail, Ahmed M. Abdelrady, Eman A. Toraih, Walid Kamal Abdelbasset, Rehab M. Lashine, Mohammed EL-dosoky, Sally Yussef Abed, Khalid M. Ibraheem, Manal S. Fawzy & Sawsan A. Zaitone. (2021) Differential Effect of Three Macrolide Antibiotics on Cardiac Pathology and Electrophysiology in a Myocardial Infarction Rat Model: Influence on Sodium Nav1.5 Channel Expression. Pharmaceuticals 14:7, pages 597.
Crossref
Crossref
Jia Wang, Yun Ling, Weie Zhou, Donghui Li, Yamei Deng, Xusheng Yang & Feng Zhang. (2020) Targeted analysis of six emerging derivatives or metabolites together with 25 common macrolides in milk using Quick, Easy, Cheap, Effective, Rugged and Safe extraction and ultra‐performance liquid chromatography quadrupole/electrostaticfield orbitrap mass spectrometry. Journal of Separation Science 43:19, pages 3719-3734.
Crossref
Crossref
Borje Darpo, Hongqi Xue, S. Ken Tanaka & Evan Tzanis. (2019) Randomized, Double-Blind, Placebo- and Positive-Controlled Crossover Study of the Effects of Omadacycline on QT/QTc Intervals in Healthy Subjects. Antimicrobial Agents and Chemotherapy 63:10.
Crossref
Crossref
Sean N. Avedissian, Nathaniel J. Rhodes, Tien M.H. Ng, Adupa P. Rao & Paul M. Beringer. (2019) The Potential for QT Interval Prolongation with Chronic Azithromycin Therapy in Adult Cystic Fibrosis Patients. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 39:6, pages 718-723.
Crossref
Crossref
Katherine Sibley, Jayson Chen, Lee Koetzner, Odete Mendes, Amy Kimzey, Janice Lansita & Ramiz A. Boulos. (2019) A 14-day repeat dose oral gavage range-finding study of a first-in-class CDI investigational antibiotic, in rats. Scientific Reports 9:1.
Crossref
Crossref
Paul S. Hoffman. 2019. Antibacterial Drug Discovery to Combat MDR. Antibacterial Drug Discovery to Combat MDR
145
162
.
Tolulope Rosanwo, Jennifer A. McArthur & Natasha Archer. 2019. Critical Care of the Pediatric Immunocompromised Hematology/Oncology Patient. Critical Care of the Pediatric Immunocompromised Hematology/Oncology Patient
71
93
.
Emilie Racine, Patrice Nordmann, Lucile Pantel, Matthieu Sarciaux, Marine Serri, Jessica Houard, Philippe Villain-Guillot, Anthony Demords, Carina Vingsbo Lundberg & Maxime Gualtieri. (2018)
In Vitro
and
In Vivo
Characterization of NOSO-502, a Novel Inhibitor of Bacterial Translation
. Antimicrobial Agents and Chemotherapy 62:9.
Crossref
Crossref
David F. Lehmann, William D. Eggleston & Dongliang Wang. (2018)
Validation and Clinical Utility of the
hERG IC
50:C
max
Ratio to Determine the Risk of Drug‐Induced Torsades de Pointes: A Meta‐Analysis
. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 38:3, pages 341-348.
Crossref
Crossref
Manjunath P. Pai. 2018. Drug Interactions in Infectious Diseases: Antimicrobial Drug Interactions. Drug Interactions in Infectious Diseases: Antimicrobial Drug Interactions
57
86
.
Takahiro Yamagishi, Yoshifumi Horie & Norihisa Tatarazako. (2017) Synergism between macrolide antibiotics and the azole fungicide ketoconazole in growth inhibition testing of the green alga Pseudokirchneriella subcapitata. Chemosphere 174, pages 1-7.
Crossref
Crossref
Heon Jae Jeong. (2017) A Strategy to Overcome Under-Reporting Issues of Voluntary Medication Error Reporting System, Part II: Changes in Number of Reports by a Counter-error Measure—Computerized Prescriber Order Entry. Biometrics & Biostatistics International Journal 5:5.
Crossref
Crossref
Jiesheng Kang, Yongyi Luo, Michelle Searles & David Rampe. (2017)
Observations on conducting whole-cell patch clamping of the hERG cardiac K
+
channel in pure human serum
. Journal of Applied Toxicology 37:4, pages 445-453.
Crossref
Crossref
Mohammad Asif. (2017) An Overview on Fluoroquinolone Drugs for the Treatment of Tubercular Infection. International Journal of Biosensors & Bioelectronics 2:1.
Crossref
Crossref
Shasha Rao, Clive A Prestidge, Lynn Miesel, Deb Sweeney, Dean L Shinabarger & Ramiz A Boulos. (2016) Preclinical development of Ramizol, an antibiotic belonging to a new class, for the treatment of Clostridium difficile colitis. The Journal of Antibiotics 69:12, pages 879-884.
Crossref
Crossref
S. Ken Tanaka & Stephen Villano. (2016)
In Vitro
and
In Vivo
Assessments of Cardiovascular Effects with Omadacycline
. Antimicrobial Agents and Chemotherapy 60:9, pages 5247-5253.
Crossref
Crossref
G. Michels, M. Kochanek & R. Pfister. (2015) Life-threatening cardiac arrhythmias due to drug-induced QT prolongationLebensbedrohliche kardiale Arrhythmien aufgrund Medikamenten-induzierter QT-Verlängerung. Medizinische Klinik - Intensivmedizin und Notfallmedizin 111:4, pages 302-309.
Crossref
Crossref
Markus Zeitlinger. 2016. Clinical Pharmacology: Current Topics and Case Studies. Clinical Pharmacology: Current Topics and Case Studies
265
292
.
Elena Buccellato, Mauro Melis, Chiara Biagi, Monia Donati, Domenico Motola & Alberto Vaccheri. (2015) Use of Antibiotics in Pediatrics: 8-Years Survey in Italian Hospitals. PLOS ONE 10:9, pages e0139097.
Crossref
Crossref
Evangelos J. Giamarellos-Bourboulis, Vassiliki Mylona, Anastasia Antonopoulou, Iraklis Tsangaris, Ioannis Koutelidakis, Androniki Marioli, Maria Raftogiannis, Petros Kopterides, Korina Lymberopoulou, Maria Mouktaroudi, Christos Papageorgiou, Basileios Papaziogas, Antonia-Panagiota Georgopoulou, Thomas Tsaganos, Evangelos Papadomichelakis, Charalambos Gogos, Malvina Ladas, Athina Savva, Aimilia Pelekanou, Fotini Baziaka, Pantelis Koutoukas, Theodora Kanni, Aikaterini Spyridaki, Nikolaos Maniatis, Nikolaos Pelekanos, Antigone Kotsaki, Ilia Vaki, Emmanuel E. Douzinas, Georgios Koratzanis & Apostolos Armaganidis. (2014) Effect of clarithromycin in patients with suspected Gram-negative sepsis: results of a randomized controlled trial. Journal of Antimicrobial Chemotherapy 69:4, pages 1111-1118.
Crossref
Crossref
Takahisa Furuta, Mitsushige Sugimoto, Mihoko Yamade, Takahiro Uotani, Shu Sahara, Hitomi Ichikawa, Takuma Kagami, Takanori Yamada, Satoshi Osawa, Ken Sugimoto, Hiroshi Watanabe & Kazuo Umemura. (2014) Eradication of H. pylori Infection in Patients Allergic to Penicillin Using Triple Therapy with a PPI, Metronidazole and Sitafloxacin. Internal Medicine 53:6, pages 571-575.
Crossref
Crossref
David Rampe & Arthur M. Brown. (2013) A history of the role of the hERG channel in cardiac risk assessment. Journal of Pharmacological and Toxicological Methods 68:1, pages 13-22.
Crossref
Crossref
Paul M. Tulkens, Pierre Arvis & Frank Kruesmann. (2012) Moxifloxacin Safety. Drugs in R&D 12:2, pages 71-100.
Crossref
Crossref
Manjunath P. Pai. 2011. Drug Interactions in Infectious Diseases. Drug Interactions in Infectious Diseases
243
275
.
Torben K. Becker & Sai-Ching J. Yeung. (2010) Drug-induced QT interval prolongation in cancer patients. Oncology Reviews 4:4, pages 223-232.
Crossref
Crossref
Donald J. AbrahamLester A. Mitscher. 2003. Burger's Medicinal Chemistry and Drug Discovery. Burger's Medicinal Chemistry and Drug Discovery
403
480
.
Donald J. AbrahamLester A. Mitscher, Jeffrey Aubé, Apurba Dutta & Jennifer E. Golden. 2003. Burger's Medicinal Chemistry and Drug Discovery. Burger's Medicinal Chemistry and Drug Discovery
275
368
.
Dick van Soolingen, Rogelio Hernandez-Pando, Hector Orozco, Diana Aguilar, Cecile Magis-Escurra, Leonard Amaral, Jakko van Ingen & Martin J. Boeree. (2010) The Antipsychotic Thioridazine Shows Promising Therapeutic Activity in a Mouse Model of Multidrug-Resistant Tuberculosis. PLoS ONE 5:9, pages e12640.
Crossref
Crossref
Markus Zeitlinger. 2010. Clinical Pharmacology: Current Topics and Case Studies. Clinical Pharmacology: Current Topics and Case Studies
281
308
.
Jessica C. Brimecombe, Glenn E. Kirsch & Arthur M. Brown. (2009) Test article concentrations in the hERG assay: Losses through the perfusion, solubility and stability. Journal of Pharmacological and Toxicological Methods 59:1, pages 29-34.
Crossref
Crossref
Hua Rong Lu, Eddy Vlaminckx, Andre Van de Water, Jutta Rohrbacher, An Hermans & David J. Gallacher. (2007) Corrigendum to “In-vitro experimental models for the risk assessment of antibiotic-induced QT prolongation”. European Journal of Pharmacology 577:1-3, pages 222-232.
Crossref
Crossref
L. Martín Méndez, M.J. García Sánchez, A.B. Melgar Borrego & R. Julián Vinals. (2007) Levofloxacino y fibrilación auricular. SEMERGEN - Medicina de Familia 33:6, pages 326-329.
Crossref
Crossref
Urs Boelsterli. 2007. Mechanistic Toxicology. Mechanistic Toxicology
301
308
.
A.S. Wagman & M.P. Wentland. 2007. Comprehensive Medicinal Chemistry II. Comprehensive Medicinal Chemistry II
567
596
.
T. Kaneko, T.J. Dougherty & T.V. Magee. 2007. Comprehensive Medicinal Chemistry II. Comprehensive Medicinal Chemistry II
519
566
.
Hua Rong Lu, Eddy Vlaminckx, Andre Van de Water, Jutta Rohrbacher, An Hermans & David J. Gallacher. (2006) In-vitro experimental models for the risk assessment of antibiotic-induced QT prolongation. European Journal of Pharmacology 553:1-3, pages 229-239.
Crossref
Crossref
P. Veyssier, P. Voirot, B. Begaud & C. Funck-Brentano. (2006) Tol?rance cardiaque de?la?moxifloxacine: exp?rience clinique issue d'une large ?tude observationnelle fran?aise en?pratique m?dicale usuelle (?tude IMMEDIAT). M?decine et Maladies Infectieuses 36:10, pages 505-512.
Crossref
Crossref
Todd Wisialowski, Kimberly Crimin, Juntyma Engtrakul, John O'Donnell, Bernard Fermini & Anthony A. Fossa. (2006) Differentiation of Arrhythmia Risk of the Antibacterials Moxifloxacin, Erythromycin, and Telithromycin Based on Analysis of Monophasic Action Potential Duration Alternans and Cardiac Instability. Journal of Pharmacology and Experimental Therapeutics 318:1, pages 352-359.
Crossref
Crossref
Dan Justo & David Zeltser. (2006) Torsades de pointes induced by antibiotics. European Journal of Internal Medicine 17:4, pages 254-259.
Crossref
Crossref
Ari J Alexandrou, Rona S Duncan, Anneli Sullivan, Jules C Hancox, Derek J Leishman, Harry J Witchel & Joanne L Leaney. (2006)
Mechanism of hERG K
+
channel blockade by the fluoroquinolone antibiotic moxifloxacin
. British Journal of Pharmacology 147:8, pages 905-916.
Crossref
Crossref
Sergey B. Zotchev, Alla V. Stepanchikova, Anastasia P. Sergeyko, Boris N. Sobolev, Dmitrii A. Filimonov & Vladimir V. Poroikov. (2006) Rational Design of Macrolides by Virtual Screening of Combinatorial Libraries Generated through in Silico Manipulation of Polyketide Synthases. Journal of Medicinal Chemistry 49:6, pages 2077-2087.
Crossref
Crossref
Salman Haq, Masi Khaja, Jeffery J. Holt & John Kassotis. (2006) The Effects of Intravenous Levofloxacin on the QT Interval and QT Dispersion. International Journal of Angiology 15:1, pages 16-19.
Crossref
Crossref
Lois S. Lee & Lingtak‐Neander Chan. (2012) Evaluation of a Sex‐Based Difference in the Pharmacokinetics of Digoxin. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 26:1, pages 44-50.
Crossref
Crossref
Ivana Cvetanovic, Vasant Ranade, Congrong Lin & John Somberg. (2006) The Differential Antibacterial and Gastrointestinal Effects of Erythromycin and Its Chiral Isolates. American Journal of Therapeutics 13:1, pages 48-56.
Crossref
Crossref
Colette Strnadova. (2005) The Assessment of QT/QTc Interval Prolongation in Clinical Trials: A Regulatory Perspective. Drug Information Journal 39:4, pages 407-435.
Crossref
Crossref
Ilknur Basyigit, Goksel Kahraman, Ahmet Ilgazli, Fusun Yildiz & Hasim Boyaci. (2005) The Effects of Levofloxacin on ECG Parameters and Late Potentials. American Journal of Therapeutics 12:5, pages 407-410.
Crossref
Crossref
Megan Nguyen & Eunice P. Chung. (2005) Telithromycin: The first ketolide antimicrobial. Clinical Therapeutics 27:8, pages 1144-1163.
Crossref
Crossref
Martin S. Lipsky. (2005) Ketolides in the treatment of community-acquired respiratory tract infections: A review. Current Therapeutic Research 66:3, pages 139-153.
Crossref
Crossref
Martin P. Bedigian. 2005. Cardiac Safety of Noncardiac Drugs. Cardiac Safety of Noncardiac Drugs
223
227
.
Vineet Sikri, Dhananjay Pal, Ritesh Jain, Durga Kalyani & Ashim K Mitra. (2004) Cotransport of Macrolide and Fluoroquinolones, a Beneficial Interaction Reversing P-glycoprotein Efflux. American Journal of Therapeutics 11:6, pages 433-442.
Crossref
Crossref